| Literature DB >> 23462101 |
Allie H Grossmann1, Jae Hyuk Yoo, James Clancy, Lise K Sorensen, Alanna Sedgwick, Zongzhong Tong, Kirill Ostanin, Aaron Rogers, Kenneth F Grossmann, Sheryl R Tripp, Kirk R Thomas, Crislyn D'Souza-Schorey, Shannon J Odelberg, Dean Y Li.
Abstract
β-Catenin has a dual function in cells: fortifying cadherin-based adhesion at the plasma membrane and activating transcription in the nucleus. We found that in melanoma cells, WNT5A stimulated the disruption of N-cadherin and β-catenin complexes by activating the guanosine triphosphatase adenosine diphosphate ribosylation factor 6 (ARF6). Binding of WNT5A to the Frizzled 4-LRP6 (low-density lipoprotein receptor-related protein 6) receptor complex activated ARF6, which liberated β-catenin from N-cadherin, thus increasing the pool of free β-catenin, enhancing β-catenin-mediated transcription, and stimulating invasion. In contrast to WNT5A, the guidance cue SLIT2 and its receptor ROBO1 inhibited ARF6 activation and, accordingly, stabilized the interaction of N-cadherin with β-catenin and reduced transcription and invasion. Thus, ARF6 integrated competing signals in melanoma cells, thereby enabling plasticity in the response to external cues. Moreover, small-molecule inhibition of ARF6 stabilized adherens junctions, blocked β-catenin signaling and invasiveness of melanoma cells in culture, and reduced spontaneous pulmonary metastasis in mice, suggesting that targeting ARF6 may provide a means of inhibiting WNT/β-catenin signaling in cancer.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23462101 PMCID: PMC3961043 DOI: 10.1126/scisignal.2003398
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192